Asia real estate and outbound investment news
Demographic drivers, rising healthcare spending, research-focused clusters and strong government support are providing growth opportunities for Asia Pacific life sciences and R&D platform Vita Partners, attendees learned at Mingtiandi’s 2025 Singapore Forum on Tuesday.
Vita has more than S$2 billion… Read More>>
Warburg Pincus on Thursday announced its acquisition of an office building in Tokyo’s Shinagawa ward under the private equity major’s GRC life sciences joint venture with Japanese asset manager Eastgate.
The JV picked up Shinagawa Seaside West Tower as the… Read More>>
A recently launched joint venture of US fund manager Warburg Pincus and Australia’s Lendlease has acquired a S$1.6 billion ($1.2 billion) portfolio of Singapore business parks and R&D facilities from entities linked to private equity giant Blackstone and Soilbuild Group… Read More>>
Singapore’s commercial real estate is showing signs of a pulse this month with developer Ho Bee Land announcing early Monday that it has agreed to sell a 49 percent stake in a life science complex in the city-state’s One North… Read More>>
US private equity giant Warburg Pincus and Australian real estate group Lendlease have achieved the final closing of their Asia Pacific life sciences joint venture, with the companies aiming to grow the partnership into a multi-billion-dollar platform.
The Singapore-based JV… Read More>>
Australian builder and property investor Lendlease Group has agreed to sell its Asia Pacific life sciences platform to a newly established 50:50 joint venture with US private equity giant Warburg Pincus, as the embattled builder continues to overhaul its business… Read More>>
Sinar Mas Land has introduced a fund to support biomedicine startups, research centres and health technology in the Indonesian builder’s home country.
The real estate division of the Widjaja family’s Sinar Mas conglomerate launched the vehicle this week in support… Read More>>
China’s DNE Group on Tuesday announced the establishment of a more than RMB 3.5 billion ($485 million) life science park fund to invest in an R&D project in Shanghai’s Pudong district.
Among the backers for the fund is a local… Read More>>
In today’s roundup of regional news headlines, Singaporean giant CapitaLand reveals its Geneo life science and innovation cluster to support biomedical research, and Prologis agrees to buy $3.1 billion in US warehouses from Blackstone. Also making the list, a pair… Read More>>
IGIS Asia Investment Management, the Singapore-based investment arm of South Korea’s IGIS Asset Management, has teamed up with a leading Korean biopharmaceuticals group to launch a new platform for life science real estate investments across Asia Pacific.
The venture, which… Read More>>
